Symbols

INSP

Inspire Medical·NYSE

--(--)

INSP fundamentals

INSP Q4 2025 Earnings

Inspire Medical (INSP) released its earnings on Feb 11, 2026: revenue was 269.08M (YoY +12.25%), beat estimates; EPS was 4.66 (YoY +305.22%), beat estimates.

Revenue / YoY

269.08M

+12.25%

EPS / YoY

4.66

+305.22%

Report date

Feb 11, 2026

INSP Earnings Call Summary for Q4,2025

Reimbursement Risk Drives Guidance: 2026 revenue range $950M-$1B reflects 10%-50% fee reduction uncertainty, with Q1 flat due to coding transition.
Inspire 5 Dominance: 90%+ centers now using Inspire 5, driven by 79.5% responder rate and reduced surgical complexity.
Financial Resilience: 2025 net income $420M, operating cash flow $117M; 2026 focus on 6%-8% adjusted margin despite top-line headwinds.
Strategic Mitigation: Pursuing new CPT code, expanding field clinical reps, and enhancing digital tools to maintain patient flow.

Earnings

EPS

Revenue

Revenue & Expenses

INSP has released its 2025 Q4 earnings report, with revenue of 269.08M, reflecting a YoY change of 12.25%, and net profit of 136.09M, showing a YoY change of 286.36%. The Sankey diagram below clearly presents INSP's revenue sources and cost distribution.

Key Indicators

Inspire Medical (INSP) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Inspire Medical (INSP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Inspire Medical (INSP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Inspire Medical (INSP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown